The U.S. Food and Drug Administration told staff this week it cannot guarantee work space or parking spots among the hurdles ...
The study found that just 20% of trials submitted to both the FDA and European Medicines Agency had matching evidence.
Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.
MacTel is a rare, progressive eye disease that affects the macula and causes a gradual deterioration in central vision.
Health and Human Services Secretary Robert F. Kennedy Jr. ordered the Food and Drug Administration on Monday to revise its ...